Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
28.01
+0.46 (1.67%)
Jun 30, 2026, 1:04 PM EDT - Market open
Pelthos Therapeutics Employees
Pelthos Therapeutics had 92 employees as of December 31, 2025. The number of employees increased by 81 or 736.36% compared to the previous year.
Employees
92
Change (1Y)
81
Growth (1Y)
736.36%
Revenue / Employee
$301,098
Profits / Employee
-$560,750
Market Cap
97.35M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 92 | 81 | 736.36% | 92 | 0 |
| Dec 31, 2024 | 11 | 3 | 37.50% | 4 | 7 |
| Dec 31, 2023 | 8 | 6 | 300.00% | 4 | 4 |
| Sep 30, 2023 | 3 | 0 | - | 3 | 0 |
| Dec 31, 2022 | 2 | 0 | - | 2 | 0 |
| Sep 30, 2022 | 3 | 1 | 50.00% | 3 | 0 |
| Jun 30, 2022 | 3 | - | - | 3 | 0 |
| Dec 31, 2021 | 2 | - | - | 2 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Inovio Pharmaceuticals | 112 |
| Alps Group | 93 |
| Fortress Biotech | 78 |
| PolyPid | 75 |
| Rani Therapeutics Holdings | 71 |
| Cognition Therapeutics | 14 |
| ProMIS Neurosciences | 11 |
| Rein Therapeutics | 10 |
PTHS News
- 4 weeks ago - Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Pelthos Therapeutics price target raised to $66 from $62 at Oppenheimer - TheFly
- 6 weeks ago - Pelthos Therapeutics reports Q1 EPS ($3.58), consensus ($3.09) - TheFly
- 6 weeks ago - Pelthos Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Pelthos Therapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - Pelthos Therapeutics Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Pelthos Therapeutics Announces First Quarter 2026 Financial Results - GlobeNewsWire
- 6 weeks ago - Pelthos Therapeutics Slides: Corporate presentation - Filings